Compare HALO & CAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HALO | CAVA |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 9.6B |
| IPO Year | 2001 | 2023 |
| Metric | HALO | CAVA |
|---|---|---|
| Price | $69.32 | $94.68 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 23 |
| Target Price | $78.18 | ★ $89.24 |
| AVG Volume (30 Days) | 1.2M | ★ 2.5M |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 2.56 | 0.54 |
| Revenue | $151,862,000.00 | ★ $1,179,664,000.00 |
| Revenue This Year | $28.24 | $25.71 |
| Revenue Next Year | $12.56 | $20.57 |
| P/E Ratio | ★ $26.03 | $168.67 |
| Revenue Growth | N/A | ★ 22.41 |
| 52 Week Low | $47.50 | $43.41 |
| 52 Week High | $82.22 | $97.98 |
| Indicator | HALO | CAVA |
|---|---|---|
| Relative Strength Index (RSI) | 59.68 | 69.72 |
| Support Level | $67.94 | $72.84 |
| Resistance Level | $71.53 | N/A |
| Average True Range (ATR) | 1.83 | 3.65 |
| MACD | 0.73 | 0.86 |
| Stochastic Oscillator | 96.73 | 90.88 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Cava Group Inc owns and operates a chain of restaurants. It operates a Mediterranean-inspired fast-casual restaurant brand offering menu items. The company's dips, spreads, and dressings are centrally produced and sold in grocery stores. The company's operations are conducted as two reportable segments: i) CAVA: It includes the operations of all company-owned CAVA restaurants, and ii) CAVA Foods: It includes the production of dips, spreads, and certain dressing bases used in CAVA restaurants as well as sales from the Company's consumer packaged goods business. The company generates the majority of its revenue from the CAVA segment.